Portrazza Approved for Metastatic Squamous NSCLC

The FDA has approved Portrazza (necitumumab injection) in combination with gemcitabine and cisplatin as first-line treatment for patients with metastatic squamous non-small cell lung cancer (NSCLC) who have not previously received medications for their advanced lung cancer.

Can Fatty Acid Supplementation Benefit Patients With Bipolar Disorder?

Patients with bipolar disorder had lower levels of certain omega-3 fatty acids that cross the blood-brain barrier than those without bipolar disorder, a study published in Bipolar Disorders reported.

NIAAA: Gender Gap in Alcohol Consumption Diminishing

A recent study conducted by the NIAAA has shown that differences between male and female alcohol consumption and alcohol-related harms may be diminishing in the United States.

FDA Expands Anthrax Vaccine Approval

Now sanctioned for adults 18 to 65 with known or suspected exposure

Music Can Help Doctors Develop Relationships With Patients

Cardiologist describes how showing her vulnerability through music has made her a better doctor

Exposure to Maternal Diabetes Impacts Youth Glycemic Control

Exposure to maternal diabetes in pregnancy linked to poorer glycemic control and -cell function

Microneedle, Sublative Fraction Radiofrequency Aids Acne Scars

Combined treatment found to be safe and effective for acne scars in Asian skin

Confusion Surrounding Osteoarthritis in Primary Care

Themes of complexity, dissonance, prioritization identified in video analysis of 19 OA consultations

Two States to Allow Pharmacists to Prescribe Birth Control

Contraceptives prescribed by pharmacists will be covered by insurance

Many First-Time Mothers Need More Accurate Vaccine Info

11 percent intend to spread out the recommended inoculations, survey finds